|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-12-09 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
| 14-12-09 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 0 | |
| -1.22% | -5.32% | +37.93% | -5.98% | 79.21B | |
| -1.42% | -4.79% | -20.78% | -38.31% | 58.22B | |
| +7.28% | +1.64% | +482.63% | +39.82% | 54.54B | |
| -0.56% | -4.20% | -11.00% | +27.11% | 48.89B | |
| +1.93% | -2.37% | -2.00% | +149.45% | 44.72B | |
| +1.70% | -0.72% | +47.29% | -15.33% | 31.83B | |
| -0.39% | -3.05% | +42.60% | +90.78% | 24.99B | |
| -0.85% | -8.82% | -6.07% | +164.64% | 20.95B | |
| -0.09% | -3.61% | +63.58% | +97.66% | 15.8B | |
| Average | +0.71% | -5.31% | +70.46% | +56.65% | 37.92B | |
| Weighted average by Cap. | +0.79% | -5.38% | +81.60% | +37.58% |
Historical Quotes: Cubist Pharmaceuticals Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- Stock
- Quotes Cubist Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
